![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Paladin Unveils OTC Onychomycosis Therapy
Paladin Unveils OTC Onychomycosis Therapy
August 20, 2013
Canadian specialty pharmaceutical company Paladin Labs has released Emtrix, a once-a-day topical treatment for nail fungus that shows no side effects and has no conflicts with other medications.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
21Oct